142 related articles for article (PubMed ID: 2493532)
21. Modulation of proline and glucosamine incorporation into tissue repair cells by peritoneal macrophages.
Fukasawa M; Bryant SM; Orita H; Campeau JD; DiZerega GS
J Surg Res; 1989 Feb; 46(2):166-71. PubMed ID: 2918718
[TBL] [Abstract][Full Text] [Related]
22. Incorporation of thymidine by fibroblasts: evidence for complex regulation by postsurgical macrophages.
Fukasawa M; Bryant SM; diZerega GS
J Surg Res; 1988 Nov; 45(5):460-6. PubMed ID: 3184925
[TBL] [Abstract][Full Text] [Related]
23. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
van Hinsbergh VW; Bertina RM; van Wijngaarden A; van Tilburg NH; Emeis JJ; Haverkate F
Blood; 1985 Feb; 65(2):444-51. PubMed ID: 3917696
[TBL] [Abstract][Full Text] [Related]
24. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion.
Wohlwend A; Belin D; Vassalli JD
J Immunol; 1987 Aug; 139(4):1278-84. PubMed ID: 3112228
[TBL] [Abstract][Full Text] [Related]
26. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
27. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Colucci M; Paramo JA; Collen D
J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
[TBL] [Abstract][Full Text] [Related]
28. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
Hettle JA; Balekjian E; Tung PS; Fritz IB
Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
[TBL] [Abstract][Full Text] [Related]
29. Regulation of proliferation of peritoneal tissue repair cells by peritoneal macrophages.
Fukasawa M; Campeau JD; Yanagihara DL; Rodgers KE; diZerega GS
J Surg Res; 1990 Jul; 49(1):81-7. PubMed ID: 2359298
[TBL] [Abstract][Full Text] [Related]
30. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor.
Chapman HA; Vavrin Z; Hibbs JB
Cell; 1982 Mar; 28(3):653-62. PubMed ID: 6210439
[TBL] [Abstract][Full Text] [Related]
31. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.
Gelehrter TD; Sznycer-Laszuk R
J Clin Invest; 1986 Jan; 77(1):165-9. PubMed ID: 2418059
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
33. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
Chapman HA; Stone OL
Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
[TBL] [Abstract][Full Text] [Related]
35. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
[TBL] [Abstract][Full Text] [Related]
37. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
[TBL] [Abstract][Full Text] [Related]
38. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
Pereyra-Alfonso S; Haedo A; Bal de Kier Joffé E
Int J Cancer; 1988 Jul; 42(1):59-63. PubMed ID: 3134309
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
Lacave R; Rondeau E; Ochi S; Delarue F; Schleuning WD; Sraer JD
Kidney Int; 1989 Mar; 35(3):806-11. PubMed ID: 2496257
[TBL] [Abstract][Full Text] [Related]
40. Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes.
Mayer M; Finci Z; Chaouat M
J Mol Cell Cardiol; 1986 Nov; 18(11):1117-24. PubMed ID: 2948022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
